Dendritic cell, mouse, immat. - BALB/c

Immature dendritic cells that take up antigen and later become antigen-presenting cells (APC) that activate T lymphocytes)

Cell Type:
Dendritic cell (DC)
Tissue Origin:
Research Area:
Immunotherapy / Hematology
Cell Characteristics:

Transfection Information

Lonza Optimized Protocol
Optimization Guideline
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our optimization strategy to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol Kit Program Cells Efficiency Viable Cells Substrate Format Platform
P4 DK-100-AA 5e4 44-50% 74% Plasmid (general) 0.4 µg 20 µl 384-well
P4 DJ-100-AA 5e4 28-34% 98% Plasmid (general) 0.4 µg 20 µl 384-well
P4 96-DK-100 5e4 43% ±4 37% ±7 Plasmid (general) 0.4 µg 20 µl 96-well
DC, mouse Y-001 3e5 58% ±3 62% ±7 Plasmid (general) 2 µg 100 µl I/II/2b


5e4 39-47% 30-44% Plasmid (general) 0.4 µg 20 µl 4D X-Unit
5e4 Plasmid (general) 20 µl 384-well